This study was a prospective observational study involving existing local patients in Singapore General Hospital, Singapore, who underwent total knee arthroplasty (TKA) and were on a short course of chemothromboprophylaxis (< 7 days) after the operation. The incidence of DVT in patients was evaluated using DVT imaging 4-6 days after the operation and at one month after the operation.
I NTRO D U C TIO N
The latest American College of Chest Physicians (ACCP) guidelines recommend the use of antithrombotic prophylaxis (e.g. low-molecular-weight heparin or warfarin, rivoroxaban, fondaparinux and apixaban) for a duration of at least 7-10 days after elective knee arthroplasties.
(1) These guidelines also recommend the extended use of prophylaxis, up to 35 days after the operation, in patients with a high risk of developing venous thromboembolism (VTE). Patients with a high risk of developing VTE include patients with active malignancies or previous VTE. Many orthopaedic surgeons believe that these recommendations are biased toward reducing deep venous thrombosis (DVT) at the expense of lower wound complications, which few surgeons are willing to accept. Furthermore, the incidence of pulmonary embolism is low regardless of the type of prophylaxis used.
We conducted a prospective observational study that looked at the incidence of DVT, as well as the time course of the development of DVT in the local population. Our study also aimed to examine the efficacy of the use of a short course of chemothromboprophylaxis (< 7 days) in the prevention of venous thromboembolic events, to enable the objective evaluation of whether the ACCP recommendations are suitable for our local cohort of patients. embolism. In 2008, the American College of Chest Physicians (ACCP) published specific guidelines recommending the use of low-molecular-weight heparin or warfarin, and a target international normalised ratio of 2.0-3.0 for a duration of at least 7-10 days, after elective knee arthroplasties. Many orthopaedic surgeons believe that these recommendations are biased toward reducing deep venous thrombosis (DVT), but neglect the implicated possibility of a higher incidence of wound complications. In order to enable an objective evaluation of the fit of the ACCP recommendations to the needs of our local cohort of patients, we aimed to look at the incidence of DVT in our local population.
M E TH O DS
(current or previous), no spinal cord injury or other conditions that limit mobility, and no serious infections.
Prospective data of the patients, including their biodata, the types of chemothromboprophylaxis used, the period of initiation and duration of chemothromboprophylaxis use, as well as the rates of venous thromboembolic complication due to the use of chemothromboprophylaxis, was collected. The endpoint of the study was to determine the incidence of DVT in our local cohort. The incidence of DVT was determined using duplex ultrasonography, which was performed during the early postoperative days (postoperative Days 4-6), and one month after the operation. Such surveillance imaging was conducted on both the operated and non-operated lower limbs. DVT was diagnosed based on the criteria of visualisation of the thrombosis and the loss of compressibility of the vein.
Chi-square test was used to assess the categorical variables (e.g. sex and type of chemothromboprophylaxis used), while unpaired two-tailed t-test was used to assess the significance of the continuous variables (e.g. age and duration of chemothromboprophylaxis use).
RESUlTS
Of the 125 patients recruited, only 100 patients completed the required postoperative imaging (one at postoperative Days 4-6 and another one month after the operation). Among these 100 patients, 52 had the operation done on their right knee, while 48 had the operation done on the contralateral side. The majority (76/100) of the patients were female. The incidence of DVT post total knee arthroplasty (TKA) was 12% during postoperative Days 4-6 and 9% one month after the operation (Table I) . At both the early postoperative period (i.e. postoperative Days 4-6) and one month after the operation, only 2% of the DVT were symptomatic. The rest of the DVT detected were asymptomatic.
In the early postoperative period, 10% of the distal DVT and 1% of the proximal DVT correlated with the operated site. Only 1% of the distal DVT was detected on a nonoperated site. One month after TKA, 7% of the distal DVT detected correlated with the site of operation, while 1% of the proximal DVT and 1% of the distal DVT were detected on the contralateral site of the operated limb.
Interestingly, 7 of the 9 cases of DVT detected one month after TKA were new cases that were not detected in the initial imaging conducted during postoperative Days 4-6. Only 2 of these 9 cases were detected previously. Of the 12 cases of DVT that were detected during the early postoperative period, 10 (83%) resolved without causing pulmonary embolism.
When we compared the patients with and without DVT in the early postoperative period, we found no significant correlation between the incidence of DVT and age, gender, duration of chemothromboprophylaxis, type of chemothromboprophylaxis, and length of stay (Table II) . There was also no significant correlation between the incidence of DVT and the aforementioned factors when patients with and without DVT at one month after TKA were compared (Table III) . There were no reported complications related to the use of chemothromboprophylaxis in our cohort. In other words, wound haematoma, bleeding and other complications related to bleeding were not an issue with the use of a short course of chemothromboprophylaxis.
D I SCU S S IO N
Since DVT can result in life-threatening conditions such as pulmonary embolism, it is one of the most dreaded 
There are reports that thromboembolic events are rare in Asia. (5) Studies have reported the incidence of proximal DVT in Asians to be only about 0.8%-1.6%. (6, 7) In a largescale prospective cohort study involving 128,934 patients, Klatsky et al also reported a lower incidence of DVT in Asians compared to other ethnic groups. (8) This difference in the incidence of DVT has been postulated to be due to the lack of prothrombotic clotting factor polymorphisms among Asians. (9) (10) (11) Furthermore, although studies conducted by Wang et al (10) and Nathan et al (11) reported the incidence of all types of DVT to be as high as 64%, the incidence of pulmonary embolism was still low in those studies.
In our study, we observed an incidence of proximal DVT of only 1% in both the early postoperative period and one month after TKA, with no clinical progression to pulmonary embolism. The overall DVT incidence was only 12% in the early postoperative period, and 9% one month after TKA. revealed that 86% of the eventually-positive limbs were already positive within a day after surgery. (12) They reported an incidence of total DVT of 47% during the early postoperative period and 54% during the late period.
The incidence of major bleeding after TKA is 3%-6% in patients given chemothromboprophylactic agents. (4, (13) (14) (15) (16) (17) (18) It is noteworthy that the patients in our study, who were on a short course of chemothromboprophylaxis (< 7 days), did not have any significant major bleeding complications. The results of our study highlight the advantages of administering a short course of chemothromboprophylaxis (< 7 days), as the complication rate mimics that of patients not taking chemothromboprophylaxis. This would allay many orthopaedic surgeons' concern regarding the use of anticoagulation chemoprophylaxis and its associated risk of bleeding, blood transfusion and periprosthetic infection. 
R EFER EN CE S

